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Razoxane (ICRF 159) is a phase-
specific cytotoxic drug. Under certain
conditions it prevents cell division in
EMT6 mouse tumour cells, but allows
DNA synthesis to continue at almost the
normal rate (Taylor and Bleehen, 1977).
The DNA content of cells exposed to
10 jig/ml Razoxane is 4 x that of normal
G 1 cells after a 24 h exposure (cell cycle
time 12 h) and continues to increase
with drug-exposure time. We have found,
however, that if the drug is removed at
24 h, the cells will divide and begin to
proliferate. Two hundred cells treated in
this way were plated out into Petri dishes
at a concentration of 1 cell/dish, im-
mediately after exposure to the drug. The
dishes were incubated for 3 weeks at 370C
and then examined for cell colonies. It
was found that, of the 10% of the cells
surviving thecytotoxic effects ofthe drug,
95% were polyploid, with double the usual
complement of DNA present in untreated
EMT6 cells. One of these polyploid cell
lines was selected as a representative
sample for further investigation and
cloned out once more. This was to ensure
as far as possible that the resulting
polyploid cell line was derived from a
single cell.
The DNA contents of the cells were
measured by flow cytofluorimetry (FCF).
Cells are stained with a fluorescent DNA
coupling agent, propidiumiodide (Krishan,
1975) which is then measured by passage
through a flow cell (Model 4800A Bio-
physicsCytofluorograf). TheDNAcontents
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Fig. 1. FCF analysis of EMT6 tumour
cell populations. (a) in vitro EMT6 cells;
(b) Razoxane-induced in vitro polyploid
EMT6 cells; (c) in vivo EMT6 cells and
(d) Razoxane-induced in vivo polyploid
EMT6 cells.
Ordinate gives the frequency of cells with
a nuclear DNA content shown on the
abscissa. N represents cell ploidy, 3N and
6N being the normal pre- and post-S-phase
DNA content.
are presented as a histogram. Each
histogram represents a sample of 10,000
cells.
Fig. 1(a) shows the DNA content of an
exponentially growing asynchronous popu-
lation of in vitro EMT6 cells. As the
EMT6 cell line has - 50% more chromo-
somes than the mouse host, the ploidy is
shown as 3-6n. Most of the cells have a
DNA content corresponding to G 1 or
S phase, with relatively few cells in G 2.
The DNA content of an in vitro poly-
ploid cell line, derived from a single clone
after ICRF 159 treatment, is shown inI. W. TAYLOR AND N. M. BLEEHEN
Fig. 1(b). The distribution is similar to
that of the normal EMT6 cells.
However, the DNA content is twice
normal and all cells have a ploidy of
6-12n. The mean diameter of the poly-
ploid cells was found to be 1-3 that of
the normal EMT6 cells, which in terms of
cell volume represents a factor of 2.
The chromosome contents of the in
vitro normal and polyploid cell lines are
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Fig. 2.- Distribution in chromosome content
of normal an(d polyploid EMAT6 cells
grown itn vitro.
a mean chromosome number of 68 com-
pared with 130 for the polyploid cells. The
chromosome number of the polyploid line
is not quite double that of the normal
EMT6 line, but difficulties in counting
these chromosomes were encountered due
to the large numbers present and the 400
deviation from perfect doubling ofchromo-
some numbers may well be accounted for
by counting errors.
Representative samples of the chromo-
some spreads for each cell line are shown
in Fig. 3. Five to 6 metacentric marker
chromosomes, not normal to the mouse
karotype, were found in all normal EMT6
cells, and twice that number in the poly-
ploid cells.
The relative growth rates of the two
cell lines as monolayers in plastic flasks
are shown in Fig. 4. All cultures had the
medium renewed from Day 2. After an
initial lag of 24 h, normal EMT6 cells
increase in number exponentially between
Days 1 and 3, with a doubling time of
12-14 h. After Day 3, the rate of
growth decreases as the flasks become
confluent, and by Day 5 a plateau in cell
numbers is reached at about 1-5 x 107
cells/flask. The growth characteristic of
the polyploid line is similar, but the cell
doubling time is significantly longer (18 h)
and the cells are stillgrowing exponentially
on Day 4. The plateau in cell numbers also
occurs at the lower number of 8 x 106
cells/flask. This could be accounted for by
the increased cell diameter of these cells
resulting in confluent conditions at a
lower cell level.
Cells of the EMT6 in vrio cell line were
treated in vivo to determine whether
polyploid cells produced by Razoxane
were capable ofgrowing as a solid tumour.
Two hundred drug-treated cells were
cloned into Petri dishes, and 12% survived
the drug treatment to form cell colonies.
All subsequent cell populations arising
from these clones were found to be
capable ofgrowing as a solid tumour when
inoculated into BALB/c mice, and of
these, 92% had twice the normal EMT6
DNA content. Again one of the polyploid
cell lines was selected for further in-
vestigation and cloned once more.
Fig. 1(c) shows the DNA content of a
normal EMT6 solid tumour. The first
peak represents mouse diploid cells, macro-
phages and lymphocytes, found in this
tumour. The tumour cells have a 3-6n
DNA content and most of the cells are
in G 1. The corresponding polyploid
tumouris shown in Fig. 1(d), and although
the diploid peak is present, no tumour
cells with a 3n DNA content are found.
All the tumour cells have a 6-12n DNA
content.
The growth of normal and polyploid
tumours was compared (Fig. 4) and no
significant difference in growth rates was
found. Both tumours had a volume-
doubling time of about 2 days. However,
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FIG. 4.-Growth curves fornormal (A) and polyploid (0) EMT6 cells. Each point on the in vivo growth
(left panel) represents the mean volume obtained from 15 animals, after inoculation of 105 cells
intra-dermally on Day 0. The right panel shows the in vitro growth curves, and each point repre-
sents the mean cell count from 4 flasks.
no similarity is implied for the more
complex kinetic parameters of cell-cycle
time, growth fraction or cell-loss factors.
Both the in vitro and in vivo polyploid
cell lines have been routinely passaged
since their origin some 6 months ago. In
terms of DNA content, chromosome
number and growth characteristics, both
of these cell lines have remained stable
over this period.
By further treatment of the polyploid
cells with Razoxane, cell populations con-
taining 4 x the normal DNA content can
be obtained, but we are as yet unable to
comment on the stability of these cells.
Many studies have been made on the
effects of gene dosage on specific aspects
of cell behaviour and function. The higher
plants have been most commonly used in
this work due to their large intra-specific
variation in ploidy (Underbrink and Pond,
1976). In comparison, the variation in
ploidy within mammalian species is rela-
tively small. It is possible to select out
polyploid variants of some mammalian
tumour cell lines (Millar and Miller, 1977)
but these are frequently unstable and of
necessity restrict further experimentation
to the cell line in question. A more flexible
technique for producing polyploid mam-
malian cells is that of chemical induction.
Many chemicalagents, particularlythose
which interfere with the mitotic spindle,
are capable of causing polyploidization.
However, as far as we are aware, only
colcemid (McBurney, 1976) colchicine
(Kleinfeld and Sisken, 1966; Palitti and
Rizzoni, 1972; Rizzoni and Palitti, 1973)
and cytochalasin B (Carter, 1967; Defendi
and Stoker, 1973) have previously been
reported to induce stable polyploid mam-
malian cell lines, which are also capable of
growing in vivo in a suitable host.
Unlike these 3 agents, Razoxane is used
clinically as a chemotherapeutic agent
alone or in combination with radiotherapy,
as a treatment for human neoplasms.
IfthepolyploidcellsproducedbyRazoxan,
prove to be resistant to either further
drug challenge or to radiotherapy, they
could provide the foci for tumour re-
growth after treatment. It is important,
therefore, that the relative sensitivity of
these polyploid cells, to both drugs and
radiation is examined.
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